Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats

Neuropharmacology

Volumn 62, Issue 3, 2012, Pages 1422-1431

  Amitai, Nurith ^a   Kuczenski, Ronald ^a   Behrens, M Margarita ^b   Markou, Athina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Antipsychotic; Clozapine; Cognition; GABA; Glutamate; Phencyclidine; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; CLOZAPINE; GLUTAMATE DECARBOXYLASE 67; GLUTAMIC ACID; PARVALBUMIN; PHENCYCLIDINE;

AMINO ACID SYNTHESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; COGNITION; COGNITIVE DEFECT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; MICRODIALYSIS; MOLECULAR PATHOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SCHIZOPHRENIA;

ANIMALS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; PHENCYCLIDINE; PREFRONTAL CORTEX; RATS; RATS, WISTAR;

EID: 84856101673     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.01.008     Document Type: Article

References (71)

1. Z. Abdul-Monim, G.P. Reynolds, and J.C. Neill The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm Behav. Brain Res. 169 2006 263 273
2. T. Abekawa, M. Honda, K. Ito, and T. Koyama Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and a1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats Psychopharmacology (Berl) 169 2003 247 256 (Pubitemid 37255517)
3. T. Abekawa, K. Ito, and T. Koyama Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex Naunyn Schmiedebergs Arch. Pharmacol. 374 2006 177 193 (Pubitemid 44819251)
4. T. Abekawa, K. Ito, and T. Koyama Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic Naunyn Schmiedebergs Arch. Pharmacol. 375 2007 261 271 (Pubitemid 46701627)
5. B. Adams, and B. Moghaddam Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine J. Neurosci. 18 1998 5545 5554 (Pubitemid 28311969)
6. B.W. Adams, and B. Moghaddam Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex Biol. Psychiatry 50 2001 750 757 (Pubitemid 33086762)
7. C.M. Adler, T.E. Goldberg, A.K. Malhotra, D. Pickar, and A. Breier Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers Biol. Psychiatry 43 1998 811 816 (Pubitemid 28288379)
8. S. Akbarian, J.J. Kim, S.G. Potkin, J.O. Hagman, A. Tafazzoli, W.E. Bunney Jr.; and E.G. Jones Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics Arch. Gen. Psychiatry 52 1995 258 266
9. N. Amitai, and A. Markou Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment Pharmacol. Biochem. Behav. 93 2009 248 257
10. N. Amitai, and A. Markou Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration Psychopharmacology (Berl) 202 2009 275 286
11. N. Amitai, and A. Markou Disruption of performance in the five-choice serial reaction time task induced by repeated administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia Biol. Psychiatry 68 2010 5 16
12. N. Amitai, and A. Markou Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats Eur. J. Pharmacol. 639 2010 67 80
13. N. Amitai, S. Semenova, and A. Markou Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats Psychopharmacology (Berl) 193 2007 521 537 (Pubitemid 47094377)
14. N. Amitai, S. Semenova, and A. Markou Clozapine attenuates disruptions in response inhibition and task efficiency induced by repeated phencyclidine administration in the intracranial self-stimulation procedure Eur. J. Pharmacol. 602 2009 78 84
15. H. Asada, Y. Kawamura, K. Maruyama, H. Kume, R.G. Ding, N. Kanbara, H. Kuzume, M. Sanbo, T. Yagi, and K. Obata Cleft palate and decreased brain γ-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase Proc. Natl. Acad. Sci. U. S. A. 94 1997 6496 6499 (Pubitemid 27270713)
16. M. Bartos, I. Vida, and P. Jonas Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks Nat. Rev. Neurosci. 8 2007 45 56 (Pubitemid 46011998)
17. C.L. Beasley, and G.P. Reynolds Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics Schizophr. Res. 24 1997 349 355 (Pubitemid 27163247)
18. C.L. Beasley, Z.J. Zhang, I. Patten, and G.P. Reynolds Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins Biol. Psychiatry 52 2002 708 715
19. M.M. Behrens, S.S. Ali, D.N. Dao, J. Lucero, G. Shekhtman, K.L. Quick, and L.L. Dugan Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase Science 318 2007 1645 1647 (Pubitemid 350233667)
20. F.M. Benes, and S. Berretta GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder Neuropsychopharmacology 25 2001 1 27 (Pubitemid 32493819)
21. J.A. Cardin, M. Carlén, K. Meletis, U. Knoblich, F. Zhang, K. Deisseroth, L.H. Tsai, and C.I. Moore Driving fast-spiking cells induces gamma rhythm and controls sensory responses Nature 459 2009 663 667
22. H.S. Cho, D.C. D'Souza, R. Gueorguieva, E.B. Perry, S. Madonick, L.P. Karper, A. Abi-Dargham, A. Belger, W. Abi-Saab, D. Lipschitz, A. Bennet, J.P. Seibyl, and J.H. Krystal Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine Psychopharmacology (Berl) 179 2005 136 143 (Pubitemid 40576700)
23. S.M. Cochran, M. Kennedy, C.E. McKerchar, L.J. Steward, J.A. Pratt, and B.J. Morris Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs Neuropsychopharmacology 28 2003 265 275
24. M. Didriksen, T. Skarsfeldt, and J. Arnt Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics Psychopharmacology (Berl) 193 2007 225 233 (Pubitemid 47025022)
25. B. Elvevag, and T.E. Goldberg Cognitive impairment in schizophrenia is the core of the disorder Crit. Rev. Neurobiol. 14 2000 1 21 (Pubitemid 32193047)
26. N.B. Farber, J.W. Newcomer, and J.W. Olney The glutamate synapse in neuropsychiatric disorders: focus on schizophrenia and Alzheimer's disease Prog. Brain Res. 116 1998 421 437 (Pubitemid 28526951)
27. J.M. Fuster Unit activity in prefrontal cortex during delayed-response performance: neuronal correlates of transient memory J. Neurophysiol. 36 1973 61 78
28. B. Grayson, N.F. Idris, and J.C. Neill Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat Behav. Brain Res. 184 2007 31 38 (Pubitemid 47404650)
29. H.C.R. Grunze, D.G. Rainnie, M.E. Hasselmo, E. Barkai, E.F. Hearn, R.W. McCarley, and R.W. Greene NMDA-dependent modulation of CA1 local circuit inhibition J. Neurosci. 76 1996 2034 2043 (Pubitemid 26144016)
30. A. Guidotti, J. Auta, J.M. Davis, V. Di-Giorgi-Gerevini, Y. Dwivedi, D.R. Grayson, F. Impagnatiello, G. Pandey, C. Pesold, R. Sharma, D. Uzunov, and E. Costa Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study Arch. Gen. Psychiatry 57 2000 1061 1069
31. K. Hashimoto, Y. Fujita, E. Shimizu, and M. Iyo Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol Eur. J. Pharmacol. 519 2005 114 117 (Pubitemid 43181173)
32. T. Hashimoto, D.W. Volk, S.M. Eggan, K. Mirnics, J.N. Pierri, Z. Sun, A.R. Sampson, and D.A. Lewis Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia J. Neurosci. 23 2003 6315 6326 (Pubitemid 36875633)
33. H. Homayoun, and B. Moghaddam NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons J. Neurosci. 24 2007 11496 11500 (Pubitemid 350006886)
34. N.F. Idris, P. Repeto, J.C. Neill, and C.H. Large Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat Psychopharmacology (Berl) 179 2005 336 348
35. D.C. Javitt, and S.R. Zukin Recent advances in the phencyclidine model of schizophrenia. Am J. Psychiatry 148 1991 1301 1308
36. J.D. Jentsch, L. Dazzi, J.P. Chhatwal, C.D. Verrico, and R.H. Roth Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats Neurosci. Lett. 258 1998 175 178 (Pubitemid 29023576)
37. J.D. Jentsch, and R.H. Roth The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology 20 1999 201 225 (Pubitemid 29067401)
38. Y. Kawaguchi, and S. Kondo Parvalbumin, somatostatin and cholecystokinin as chemical markers for specific GABAergic interneuron types in the rat frontal cortex J. Neurocytol 31 2002 277 287 (Pubitemid 36877376)
39. J.W. Kinney, C.N. Davis, I. Tabarean, B. Conti, T. Bartfai, and M.M. Behrens A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons J. Neurosci. 26 2006 1604 1615 (Pubitemid 43237031)
40. M.B. Knable, B.M. Barci, J.J. Bartko, M.J. Webster, and E.F. Torrey Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers Mol. Psychiatry 7 2002 392 404 (Pubitemid 34499361)
41. J.H. Krystal, D.C. D'Souza, D. Mathalon, E. Perry, A. Belger, and R. Hoffman NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development Psychopharmacology (Berl) 169 2003 215 233 (Pubitemid 37264943)
42. J.H. Krystal, L.P. Karper, J.P. Seibyl, G.K. Freeman, R. Delaney, J.D. Bremner, G.R. Heninger, M.B. Bowers Jr.; and D.S. Charney Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch. Gen. Psychiatry 51 1994 199 214 (Pubitemid 24081509)
43. R. Kuczenski, and D. Segal Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis J. Neurosci. 9 1989 2051 2065 (Pubitemid 19156992)
44. D.A. Lewis, D.W. Volk, and T. Hashimoto Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction Psychopharmacology (Berl) 174 2004 143 150 (Pubitemid 38925099)
45. Q. Li, S. Clark, D.V. Lewis, and W.A. Wilson NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity J. Neurosci. 22 2002 3070 3080 (Pubitemid 35379196)
46. X. López-Gil, Z. Babot, M. Amargós-Bosch, C. Suñol, F. Artigas, and A. Adell Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat Neuropsychopharmacology 32 2007 2087 2097 (Pubitemid 47417703)
47. A.K. Malhotra, D.A. Pinals, H. Weingartner, K. Sirocco, C.D. Missar, D. Pickar, and A. Breier NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers Neuropsychopharmacology 14 1996 301 307 (Pubitemid 26151927)
48. J.M. Mathé, G.G. Nomikos, B. Schilström, and T.H. Svensson Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens J. Neurosci. Res. 51 1998 583 592 (Pubitemid 28115059)
49. S.M. Melnick, J.S. Rodriguez, R.E. Bernardi, and A. Ettenberg A simple procedure for assessing ataxia in rats: effects of phencyclidine Pharmacol. Biochem. Behav. 72 2002 125 130 (Pubitemid 34251318)
50. H.Y. Meltzer, P.S. Holzman, S.Z. Hassan, and A. Guschwan Effects of phencyclidine and stress on plasma creatine phosphokinase (CPK) and aldolase activities in man Psychopharmacologia 26 1972 44 53
51. H.Y. Meltzer, and S.R. McGurk The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia Schizophr. Bull. 25 1999 233 255 (Pubitemid 29272503)
52. B. Moghaddam, B. Adams, A. Verma, and D. Daly Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J. Neurosci. 17 1997 2921 2927 (Pubitemid 27155025)
53. B.A. Morrow, J.D. Elsworth, and R.H. Roth Repeated phencyclidine in monkeys results in loss of parvalbumin-containing axo-axonic projections in the prefrontal cortex Psychopharmacology (Berl) 192 2007 283 290 (Pubitemid 46669209)
54. J.W. Olney, and N.B. Farber Glutamate receptor dysfunction and schizophrenia Arch. Gen. Psychiatry 52 1995 998 1007
55. L. Paulson, P. Martin, A. Persson, C.L. Nilsson, E. Ljung, A. Westman-Brinkmalm, P.S. Eriksson, K. Blennow, and P. Davidsson Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats J. Neurosci. Res. 71 2003 526 533 (Pubitemid 36158336)
56. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates second ed. 1986 Academic Press New York
57. J.N. Pierri, A.S. Chaudry, T.U. Woo, and D.A. Lewis Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects Am. J. Psychiatry 156 1999 1709 1719 (Pubitemid 29517562)
58. J. Podhorna, and M. Didriksen Performance of male C57BL/6J mice and Wistar rats in the water maze following various schedules of phencyclidine treatment Behav. Pharmacol. 16 2005 25 34 (Pubitemid 40354363)
59. S.N. Pradhan Phencyclidine (PCP): some human studies Neurosci. Biobehav. Rev. 8 1984 493 501 (Pubitemid 15155160)
60. T.W. Robbins Dissociating executive functions of the prefrontal cortex Philos. Trans. R. Soc. Lond. B. Biol. Sci. 351 1996 1463 1471 (Pubitemid 27005373)
61. G. Rosenbaum, B.D. Cohen, E.D. Luby, J.S. Gottlieb, and D. Yelen Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (Amytal) sodium: I. Attention, motor function, and proprioception Arch. Gen. Psychiatry 1 1959 651 656
62. V.S. Sohal, F. Zhang, O. Yizhar, and K. Deisseroth Parvalbumin neurons and gamma rhythms enhance cortical circuit performance Nature 459 2009 698 702
63. D.P. Stanley, and A.K. Shetty Aging in the rat hippocampus is associated with widespread reductions in the number of glutamate decarboxylase-67 positive interneurons but not interneuron degeneration J. Neurochem. 89 2004 204 216 (Pubitemid 38420690)
64. C.A. Tamminga Schizophrenia and glutamatergic transmission Crit. Rev. Neurobiol. 12 1998 21 36 (Pubitemid 28177262)
65. D. Volk, M. Austin, J. Pierri, A. Sampson, and D. Lewis GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons Am. J. Psychiatry 158 2001 256 265 (Pubitemid 32116522)
66. D.W. Volk, M.C. Austin, J.N. Pierri, A.R. Sampson, and D.A. Lewis Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical γ-aminobutyric acid neurons in subjects with schizophrenia Arch. Gen. Psychiatry 57 2000 237 245 (Pubitemid 30140433)
67. F. Wang, H. Chen, and B.M. Sharp Neuroadaptive changes in the mesocortical glutamatergic system during chronic nicotine self-administration and after extinction in rats J. Neurochem. 106 2008 943 956
68. D.R. Weinberger, K.F. Berman, and R.F. Zec Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow evidence Arch. Gen. Psychiatry 43 1986 114 124 (Pubitemid 16163530)
69. T.U. Woo, R.E. Whitehead, D.S. Melchitzky, and D.A. Lewis A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia Proc. Natl. Acad. Sci. U. S. A. 95 1998 5341 5346 (Pubitemid 28208599)
70. Y. Yonezawa, T. Kuroki, T. Kawahara, N. Tashiro, and H. Uchimura Involvement of γ-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex Eur. J. Pharmacol. 341 1998 45 56 (Pubitemid 28041197)
71. Y. Zhang, M.M. Behrens, and J.E. Lisman Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex J. Neurophysiol. 100 2008 959 965